In the current treatment era and in the absence of recurrent herpes simplex outbreaks, any value for chronic acyclovir administration, even at the most well-proven dose of 3.2 g/day, is questionable.

OBJECTIVES The frequency and characteristics of the long term sequelae of herpes simplex encephalitis were assessed after treatment with acyclovir. METHODS Patients were included if they were treated ...